School-Based Preventive Asthma Care Technology: A Trial Using a Novel Technology to Improve Adherence

Not Applicable

Completed

Brief Summary: The goal of this new translational project is to test the feasibility and effectiveness of implementing school-based directly observed therapy of preventive asthma medications in a real-world setting, using state-of-the-art web-based technology for systematic screening, electronic report generation, and communication between nurses, caregivers, and primary care providers. With the use of a novel method to improve adherence and subsequently reduce morbidity, the investigators hypothesize that this novel adaptation of school-based asthma care will; 1) be feasible and acceptable among this population and among school and community stakeholders, and 2) yield reduced asthma morbidity (symptom-free days, absenteeism, and emergency room / urgent care use for asthma care). The investigators anticipate that enhancing preventive healthcare for young urban children with asthma through partnerships with the schools using a novel technology will yield improved health, prevention of suffering, decreased absenteeism from school, and reduced healthcare costs.

Recruitment & Eligibility

Inclusion Criteria

Not provided

Exclusion Criteria

Inability to speak and understand English. (*Parents unable to read will be eligible, and all instruments will be given verbally.)
No access to a working phone for follow-up surveys (either at the subject's home or an easily accessible alternate phone number).
Family planning to leave the school district within fewer than 6 months.
The child having other significant medical conditions, including congenital heart disease, cystic fibrosis, or other chronic lung disease, that could interfere with the assessment of asthma-related measures.
Children in foster care or other situations in which consent cannot be obtained from a guardian.

Arm && Interventions

Group	Intervention	Description
School-Based Medication Group	School-Based Medication Delivery	For children assigned to the School-Based Medication group, an asthma coordinator will send the child's primary care physician a report indicating the child's asthma symptoms, and will recommend that the child receive a preventive asthma medication at school. If the child's doctor agrees, the preventive asthma medication will be delivered to the child's school and to his/her home by a local pharmacy. The child's school nurse will begin directly observed therapy of the preventive asthma medication at school, and will routinely assess the child's asthma symptoms throughout the school year.

Primary Outcome Measures

Name	Time	Method
Average Number of Symptom-free Days Over 14 Days; (Symptom-free Days Are Averaged Over 4 Bi-monthly Follow-ups)	Average number of days, over 2 weeks, throughout the school year	The primary outcome is asthma morbidity between groups. We will measure asthma morbidity by looking at the average number of symptom-free days, over 2 weeks, at each bi-monthly follow-up time point over the school year. Number of days without asthma symptoms will be reported by the child's caregiver.

Secondary Outcome Measures

Name	Time	Method
Feasibility and Acceptability	one year	We will conduct interviews with parents and school nurses to evaluate whether this new program is feasible and acceptable among this population.
Cost Effectiveness	one year	We will evaluate the cost effectiveness to implement and sustain the web-based system in schools. We will review the cost of the intervention using three main categories of costs; programmatic costs (costs of initiating and running the program), productivity costs, and medical costs estimated at the individual child level.